Evidence map›Paper›PMID 33919847›Full record

ReviewInternational journal of molecular sciences2021

Prophylaxis and Treatment against

Vanessa Arato, Maria Michelina Raso, Gianmarco Gasperini, Francesco Berlanda Scorza, Francesca Micoli

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Materials today. Bio · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Characterization of Carbapenem-ResistantInfection and drug resistance · 2026
    Article
  14. Article
  15. Frontiers in microbiology · 2026
    Review
  16. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vanessa AratoGSK Vaccines Institute for Global Health (GVGH) S.r.l., via Fiorentina 1, 53100 Siena, Italy.
Maria Michelina RasoGSK Vaccines Institute for Global Health (GVGH) S.r.l., via Fiorentina 1, 53100 Siena, Italy.ORCID 0000-0001-6183-965X
Gianmarco GasperiniGSK Vaccines Institute for Global Health (GVGH) S.r.l., via Fiorentina 1, 53100 Siena, Italy.
Francesco Berlanda ScorzaGSK Vaccines Institute for Global Health (GVGH) S.r.l., via Fiorentina 1, 53100 Siena, Italy.
Francesca MicoliGSK Vaccines Institute for Global Health (GVGH) S.r.l., via Fiorentina 1, 53100 Siena, Italy.
Toscana Life Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCarbapenemsDrug Resistance, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-LactamasesCarbapenemsanti-microbial resistanceKlebsiella pneumoniaemonoclonal antibodiesvaccines

Identifiers

PMID33919847
PMCPMC8070759
OpenAlexW3155148466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.